Compared to other killers from a public health standpoint, ADHD is worse than the top five killers in the U.S. combined. Russell Barkley, PhD, is a Clinical Professor of Psychiatry at the Virginia Commonwealth University Medical Center (VCUMC), Richmond, VA. His research findings have lit a fire under the ADHD community. Listen to excerpts of his interview with the Dr. Josh Feder and Mara Goverman as they consider the implications of ADHD and life expectancy, and how it can be addressed by clinicians.
 
Date Published: 1/23/20
 
Duration: 17 minutes, 4 seconds
 
Article Referenced: Forthcoming - "Reduced Life Expectancy in ADHD," The Carlat Child Psychiatry Report, January/February/March 2020
 
Tools Referenced: Adult ADHD Self-Report Scale (ASRS-v1.1) (https://add.org/wp-content/uploads/2015/03/adhd-questionnaire-ASRS111.pdf)
 
Take the Podcast Survey (https://www.thecarlatreport.com/podcastsurvey/) to help us launch a CME option in 2020.

ADHD and Life Expectancy with Russell Barkley, PhD

Clear, engaging, and practical updates on clinical psychiatry. Hosted by Chris Aiken, MD, and Kellie Newsome, PMHNP.    
Earn CME for listening at www.thecarlatreport.com/podcastcme

Alternative Health

Health

Medicine

Science & Medicine

Health & Fitness

Mental Health

In today's episode, Dr. Brian Hurley provides expert insights into the current state of stimulant use disorder, its implications across different regions, and available treatment options. CME: Take the CME Post-Test for this EpisodePublished On: 04/15/2024Duration: 30 minutes, 43 secondNoah Capurso, MD, Brian Hurley, MD have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Stimulant Update with Dr. Brian Hurley

Does psychiatry keep making the same mistakes? Edward Shorter gives us a historical perspective. CME: Take the CME Post-Test for this EpisodePublished On: 04/08/2024Duration: 22 minutes, 16 secondChris Aiken, MD, Edward Shorter, PhD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Controversies in Psychiatry

Viibryd has gone generic, but is it worth prescribing? We review all there is to know about vilazodone in this update from our #1 most read article of 2023.CME: Take the CME Post-Test for this EpisodePublished On: 04/01/2024Duration: 12 minutes, 47 secondChris Aiken, MD, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Viibryd Goes Generic

All sorts of medications are prescribed for anxiety in older adults. Today, we look at when and how to discontinue them.CME: Take the CME Post-Test for this EpisodePublished On: 03/25/2024Duration: 22 minutes, 47 secondChris Aiken, MD, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Deprescribing Anti-anxiety Meds in Older Adults

Today we are discussing dissociative identity disorder (DID) and related topics ﻿﻿Published On: 03/18/2024Duration: 17 minutes, 31 secondsJoshua Feder, MD, and Mara Goverman, LCSW, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

ADHD and Life Expectancy with Russell Barkley, PhD

Download our free app to listen on your phone